TWA
MRNS

TCI Wealth Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

TCI Wealth Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25
Closed – – 1813
2019
Q4 		$0 Hold
25
– – ﹤0.01% 1711
2019
Q3 		$0 Sell
25
-25
-50% -$202 ﹤0.01% 1664
2019
Q2 		$1K Hold
50
– – ﹤0.01% 1350
2019
Q1 		$1K Buy
50
+25
+100% +$360 ﹤0.01% 1347
2018
Q4 		$0 Sell
25
-75
-75% -$1.52K ﹤0.01% 1706
2018
Q3 		$4K Hold
100
– – ﹤0.01% 870
2018
Q2 		$3K Buy
+100
New +$2.22K ﹤0.01% 988

Other funds holding MRNS

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

TCI Wealth Advisors's MRNS Position: Q1 2020 in Review

TCI Wealth Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2020, closing a stake of 25 shares.

TCI Wealth Advisors first reported a position in MRNS in Q2 2018 and held it in 7 quarters. The position peaked at $4K in Q3 2018. 74 funds tracked by Wall St. Rank hold MRNS as of Q1 2020.

  • TCI Wealth Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2020 after selling out during the quarter.
  • TCI Wealth Advisors sold 25 Marinus Pharmaceuticals, Inc shares in Q1 2020.
  • TCI Wealth Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 7 quarters.
  • TCI Wealth Advisors's Marinus Pharmaceuticals, Inc position peaked at $4K in Q3 2018.
  • 74 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2020.

Based on TCI Wealth Advisors's 13F filing for Q1 2020, filed 14 Apr 2020.